Groups information

Group name

Neoadjuvant HT Group

Baseline information

Age

68 (52–77)

Age remark

median (IQR)

PSA

7.45 (4.2-49.3)

PSA remark

Initial PSA (ng/mL)

American Society of Aneshesiologists (ASA) physical status classification
Charlson comorbidity index (CCI)
Risk classification

low

9 (14.5%)

intermediate

23 (37.1%)

high

30 (48.4%)

Risk remark

D’Amico risk classification